Self-assembled nanocomplexes of polyphenol-modified prodrugs and transferrin enable cascade-targeted and redox-activated chemotherapy

studies confirmed that CSG@Tf NCs significantly improved antitumor efficacy while reducing systemic toxicity. This work presents a novel, carrier-free, and dual-functional strategy for constructing targeted prodrug nanomedicines with strong translational potential.